Jerry R. Mendell, MD
Contact Information
Jerry R. Mendell, MD, is an attending neurologist at Nationwide Children’s Hospital, the Dwight E. Peters and Juanita R. Curran Endowed Chair in Pediatric Research at the Abigail Wexner Research Institute at Nationwide Children’s Hospital and professor of Pediatrics and Neurology at Nationwide Children’s and The Ohio State University.
Dr. Mendell joined the Research Institute at Nationwide Children’s fulltime in 2004, recruited by Philip Johnson, the Head of the Center for Gene Therapy at that time. Shortly after, leadership of the Center changed and provided the opportunity to build and establish a program in Clinical Translation with emphasis on neuromuscular disease. At Nationwide Children’s, he holds academic positions as Professor of Pediatrics and Neurology and holds the Curran-Peters Chair of Pediatric Research.
He is a clinician scientist with decades of experience. A career emphasis began with training in neuromuscular disease at the National Institutes of Health, directing laboratory projects that could be carried to the bedside. He was recruited to Columbus to direct the Neuromuscular Center at Ohio State. His life’s work has emphasized clinical translation. He has published more than 370 articles with a focus on neuromuscular disease and authored books on muscle disease, peripheral nerve disorders, and most recently, gene therapy for muscle disease. He was the principal investigator on the prednisone clinical trial in DMD in 1989 that has profoundly influenced clinical care. He was the PI on the exon skipping trial using eteplirsen, now FDA approved for clinical use in 2016. He was the PI on the first gene therapy trials for DMD and LGMD and was the PI on the SMA gene therapy trial that was FDA approved for systemic delivery for infants with SMA type 1 in 2017. The results of the first systemic gene therapy trial for DMD is now moving to Phase 3. Results from the Phase 1/2 micro-dystrophin trial will be published in June 2020.
-
Neuromuscular Disorders
Physician Team -
Neurosciences
Director -
Neuromuscular Genetic Therapeutics Fellowship
Program Co-Director -
Neurology
Physician Team -
Center for Gene Therapy
Principal Investigator -
Neurology Residency
Faculty -
Primary Department
Pediatrics -
Primary Section
Neurology
- Juanita Curran and Dwight Peters Endowed Chair, 2010
- Distinguished Scholar Award, The Ohio State University, Presented by the President, 2009
- S. Mouchly Small Scientific Achievement Award, The Muscular Dystrophy Association for Significant Contributions to Neuromuscular Disease Research, 2004
- Listed, Best Doctors in America
Date of Appointment at Nationwide Children’s Hospital: 08/27/2004
Board Certifications
- Neurology
| Fellowship | National Institutes of Health | Date Completed: 07/31/1971 |
|---|---|---|
| Residency | National Institutes of Health | Date Completed: 06/30/1970 |
| Residency | Columbia Presbyterian Medical Center - New York | Date Completed: 06/30/1969 |
| Medical School | University of Texas Southwestern Medical Center | Date Completed: 06/30/1966 |
1992 - 2004 Dept of Neurology, The Ohio State University, Chair
